No Data
No Data
Australian Insurers to Benefit From Strong Investment Returns -- Market Talk
0636 GMT - The earnings lift Australian insurers have gained from higher premium rates will continue to offset reinsurance rate pressures and higher spending on technology, cyber defense and regulatio
Nib and Medibank Look to Have Similar Gross Margin Buffers -- Market Talk
0548 GMT - Australian health insurers Nib and Medibank look to have similar gross margin buffers, Goldman Sachs analysts Julian Braganza and Brian Kim say in a note. An analysis of the companies' rese
Buy or Hold? Top Broker Rates These 2 ASX 200 Shares
ASX 200 shares have hit turbulence midway through the year. The benchmark S&P/ASX 200 Index (ASX: XJO) has slipped nearly half a per cent into the red this past month.
What Is Goldman Sachs Saying About Medibank Shares in June?
Medibank Private Ltd (ASX: MPL) shares have been on form over the last six months.
3 High-Yield Dividend Stocks On ASX With Up To 7.6% Yield
The Australian stock market has shown robust performance recently, with a 1.1% increase over the last week and a notable 9.4% rise over the past year, alongside forecasts predicting annual earnings growth of 14%.
Australian Health Insurers See Continued Policyholder Growth -- Market Talk
0503 GMT - The March quarter was another strong quarter of policyholder growth for Australian health insurance companies, say Morgan Stanley analysts in a note analyzing regulatory data. Holders with
No Data